| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/26/2001 | CA2396908A1 Benzimidazole derivative |
| 07/26/2001 | CA2396870A1 Particulate blends and compacted products formed therefrom, and the preparation thereof |
| 07/26/2001 | CA2396697A1 Antisense modulation of glycogen synthase kinase 3 beta expression |
| 07/26/2001 | CA2396319A1 Ophthalmic compositions for treating ocular hypertension |
| 07/26/2001 | CA2396283A1 Human cystine knot polypeptide |
| 07/26/2001 | CA2396066A1 Drug combination for the treatment of depression and related disorders comprising mirtazapine and gepirone |
| 07/26/2001 | CA2395974A1 Multi-step drug dosage forms |
| 07/26/2001 | CA2395736A1 Novel nucleic acids and polypeptides |
| 07/26/2001 | CA2394703A1 Amide compounds for inhibiting protein kinases |
| 07/26/2001 | CA2394612A1 Antimicrobial compositions |
| 07/26/2001 | CA2393694A1 Use of particular compounds for prophylaxis and treatment of hepatitis c |
| 07/26/2001 | CA2389924A1 Use of flavone 8-acetic acid in vascular and cardiovascular interventions and acute coronary syndromes |
| 07/26/2001 | CA2388885A1 Indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation |
| 07/26/2001 | CA2365610A1 Compositions and methods for the treatment of tumor |
| 07/26/2001 | CA2365118A1 Inhibitor against human chymase activity |
| 07/26/2001 | CA2332214A1 Compositions and methods for treating osteoporosis and lowering cholesterol |
| 07/26/2001 | CA2332208A1 Pharmacophore models for, methods of screening for, and identification of the cytochrome p-450 inhibitory potency of neurokinin-1 receptor antagonists |
| 07/25/2001 | EP1118663A1 Nucleic acids encoding chemotaxis inhibitory polypeptides |
| 07/25/2001 | EP1118660A1 Enzyme producing plasma protein fragment having effect of inhibiting cancer metastasis and plasma protein fragment fragmented by the enzyme |
| 07/25/2001 | EP1118659A1 Expression systems for functional nucleic acid expression |
| 07/25/2001 | EP1118617A1 Compounds with an antioxidant acitivity, compositions useful as food integrators containing them and process for their preparation |
| 07/25/2001 | EP1118612A1 Piperazine derivatives possesing nootropic activity |
| 07/25/2001 | EP1118610A1 Benzenesulfonamide derivatives, process for their preparation and pharmaceutical compositions containing them |
| 07/25/2001 | EP1118333A1 Compositions with enhanced oral bioavailability |
| 07/25/2001 | EP1118327A1 Preventive and/or therapeutic agents for sinusitis-------------- |
| 07/25/2001 | EP1118325A2 Drug delivery systems containing microtubule stabilizing agents and the use of said agents in the manufacture of a medicament for treating atherosclerosis or restenosis |
| 07/25/2001 | EP1118324A1 Analgesic agent comprising a cyclobutanedicarboxylic acid derivative |
| 07/25/2001 | EP1118323A2 Method of reducing morbidity and the risk of mortality |
| 07/25/2001 | EP1118322A1 Drugs for improving vesical excretory strength |
| 07/25/2001 | EP1117835A1 Prevention of adhesions |
| 07/25/2001 | EP1117820A1 Fermentation of clavulanic acid at a controlled level of ammonia |
| 07/25/2001 | EP1117801A2 Polyketide synthase enzymes and recombinant dna constructs therefor |
| 07/25/2001 | EP1117796A2 Calcium channel alpha-2/delta gene |
| 07/25/2001 | EP1117791A2 Cancer associated antigens and uses therefor |
| 07/25/2001 | EP1117785A1 Human kinesin-like motor protein |
| 07/25/2001 | EP1117784A2 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity |
| 07/25/2001 | EP1117782A2 Ion channels, in particular vanilloid receptor-like (vr-l) receptor |
| 07/25/2001 | EP1117779A1 $i(MORAXELLA CATARRHALIS) PROTEIN, NUCLEIC ACID SEQUENCE AND USES THEREOF |
| 07/25/2001 | EP1117778A2 Methods and compositions for inducing differentiation and apoptosis in cells that overexpress the notch protein |
| 07/25/2001 | EP1117776A1 ENZYMATIC SYNTHESIS OF ssDNA |
| 07/25/2001 | EP1117768A1 Dnazymes and methods for treating restenosis |
| 07/25/2001 | EP1117762A1 Methods of controlling proliferation and differentiation of stem and progenitor cells |
| 07/25/2001 | EP1117689A1 Bone morphogenetic protein antagonists based on the mature protein |
| 07/25/2001 | EP1117676A1 Propanolamine derivatives linked with bile acid used for treating disorders of the lipid metabolism |
| 07/25/2001 | EP1117675A1 Cadherin-like asymmetry protein-1, and methods for its use |
| 07/25/2001 | EP1117672A1 Antisense modulation of survivin expression |
| 07/25/2001 | EP1117669A1 Antiviral purine derivatives |
| 07/25/2001 | EP1117667A1 BENZOTHIENO[3,2-c]PYRIDINES AS ALPHA2 ANTAGONISTS |
| 07/25/2001 | EP1117665A1 Photosensitizers for photodynamic applications |
| 07/25/2001 | EP1117664A1 Imidazo[4,5-c-]-pyridine-4-one derivatives with factor xa inhibiting effect |
| 07/25/2001 | EP1117663A2 2-piperazino alkylamino benzoazole derivatives: dopamine receptor subtype specific ligands |
| 07/25/2001 | EP1117662A1 Benzimidazolinyl piperidines as cgrp ligands |
| 07/25/2001 | EP1117661A1 Propanolamine derivatives substituted with heterocyclic compounds, methods for their production, pharmaceutical compositions containing said compounds and the use thereof |
| 07/25/2001 | EP1117659A1 Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors |
| 07/25/2001 | EP1117658A1 1,3-benzodiazepines with integrin inhibitory activity for use in the treatment of inflammatory disorders |
| 07/25/2001 | EP1117657A1 Phenylalanine derivatives as alpha 4 integrin inhibitors |
| 07/25/2001 | EP1117655A1 Rhodanine carboxylic acid derivatives for the treatment and prevention of metabolic bone disorders |
| 07/25/2001 | EP1117653A1 Chemical compounds |
| 07/25/2001 | EP1117652A1 Tan-1057 derivatives |
| 07/25/2001 | EP1117651A1 New bis-benzimidazoles |
| 07/25/2001 | EP1117649A1 Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors |
| 07/25/2001 | EP1117648A1 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors |
| 07/25/2001 | EP1117646A1 Phenylalkanoic acid derivatives as inhibitors of alpha4 integrins |
| 07/25/2001 | EP1117645A1 Aryl-substituted propanolamine derivatives, methods for their production, medicaments containing said compounds and their use |
| 07/25/2001 | EP1117644A1 Benzamide derivatives as thrombin inhibitors |
| 07/25/2001 | EP1117643A1 New crystal modification iii of torasemide |
| 07/25/2001 | EP1117642A1 Substituted 1,3-diaryl-2-pyridine-2-yl-3-(pyridine-2-ylamino)-propanol derivatives, methods for their production, pharmaceutical compositions containing the same and their use |
| 07/25/2001 | EP1117641A1 Indolin derivatives as sun protection agents |
| 07/25/2001 | EP1117640A1 Heterocyclic 2-substituted ketoamides useful for treating hair loss in mammals |
| 07/25/2001 | EP1117635A1 2-substituted ketoamides |
| 07/25/2001 | EP1117633A1 Diaminocyclobutene-3,4-dione derivatives, their preparation and use |
| 07/25/2001 | EP1117628A1 2, 4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors |
| 07/25/2001 | EP1117444A2 Hydrogels and water soluble polymeric carriers for drug delivery |
| 07/25/2001 | EP1117440A1 Pharmaceutical compositions containing paclitaxel |
| 07/25/2001 | EP1117439A1 Methods for identification, diagnosis, and treatment of breast cancer |
| 07/25/2001 | EP1117436A1 Neisseria spp polypeptide, nucleic acid sequence and uses thereof |
| 07/25/2001 | EP1117433A1 Anti hiv compositions comprising immunostimulatory polynucleotides and hiv antigens |
| 07/25/2001 | EP1117432A1 Carbohydrate vaccines for viral diseases |
| 07/25/2001 | EP1117427A2 USE OF $i(PEX) IN THE TREATMENT OF METABOLIC BONE DISEASES |
| 07/25/2001 | EP1117425A2 Methods for the treatment of non-thyroid disorders |
| 07/25/2001 | EP1117424A2 Null igf for the treatment of cancer |
| 07/25/2001 | EP1117416A1 Plant extracts for the treatment of increased bone resorption |
| 07/25/2001 | EP1117415A1 Use of extracts from aristolochia in the treatment of aids |
| 07/25/2001 | EP1117412A1 Compositions containing diphosphonic acids |
| 07/25/2001 | EP1117411A1 Process for the preparation of oral pharmaceutical compositions comprising biphosphonates |
| 07/25/2001 | EP1117410A1 Use of bisphosphonic acid derivatives for preparing a medicine for treating lameness |
| 07/25/2001 | EP1117409A2 Use of benzenesulfonyl(thio)ureas for the treatment of dysfunctions of the autonomous nervous system |
| 07/25/2001 | EP1117408A1 Use of diltiazem for treating retinal pathologies |
| 07/25/2001 | EP1117407A1 Oral dosage formulations comprising (2s, 3s,5r)-2-(3,5-difluorophenyl) -3,5-dimethyl-2-morpholinol and an effective stabilizing amount of alginic acid |
| 07/25/2001 | EP1117406A1 Antibiotic compositions for treatment of the eye, ear and nose |
| 07/25/2001 | EP1117405A2 Composition and method for treating allergic diseases |
| 07/25/2001 | EP1117404A1 Composition for treatment of light-injured retinal degeneration disease |
| 07/25/2001 | EP1117403A1 Mglur5 antagonists for the treatment of pain and anxiety |
| 07/25/2001 | EP1117402A2 Antibiotic compositions for treatment of the eye, ear and nose |
| 07/25/2001 | EP1117401A2 Antibiotic compositions for treatment of the eye, ear and nose |
| 07/25/2001 | EP1117400A2 Antibiotic compositions for treatment of the eye, ear and nose |
| 07/25/2001 | EP1117399A1 Use of 3-(1h-imidazol-4-ylmethyl)-indan-5-ol in the manufacture of a medicament for intraspinal, intrathecal or epidural administration |
| 07/25/2001 | EP1117398A2 A method for treating inflammatory diseases by administering a thrombin inhibitor |
| 07/25/2001 | EP1117397A1 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity |
| 07/25/2001 | EP1117396A1 A method to increase the excretion of non-sterol endogenous hydrophobic substances by increasing excretion of fat via the faeces |